Aug 12, 2020
MobileODT completed $4 million series round C
Jun 01, 2020
DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
Apr 27, 2020
Bladder Cancer: 10 Year Epidemiological Forecasts Across Seven Major Markets
Apr 27, 2020
Photocure Regains Worldwide Rights of Hexvix
Mar 30, 2020
Diverse Biotech announces collaboration with Duke University on glioblastoma research
Mar 17, 2020
Grant Awarded to Fund Promising New Research into Enhancing Efficacy of Immunotherapy
Mar 10, 2020
Hope Regional Cancer Center Is the Only Full-Service Comprehensive Cancer Center in the Bay County Area
Mar 09, 2020
Sirnaomics to Showcase Data for Lead Product STP705 in Human Squamous Carcinoma Tumor Model at 2020 American Academy of Dermatology Annual Meeting
Mar 03, 2020
The Richard M. Schulze Family Foundation Launches $2 Million Challenge Grant To Benefit the American Cancer Society Hope Lodge of Atlanta
Mar 02, 2020
Washington Poison Center Announces 2020 Poison Prevention Poster Contest Winner
Mar 02, 2020
Washington Poison Center Announces 2020 Poison Prevention Poster Contest Winner
Mar 02, 2020
Washington Poison Center Announces 2020 Poison Prevention Poster Contest Winner
Jan 15, 2020
Global Breast Cancer Drug Market & Clinical Trial Insight 2025
Jan 15, 2020
New Colorectal Cancer Guide Offers Support and Practical Help to 'Invisible' Carers
Jan 08, 2020
KDx Diagnostics announces FDA Breakthrough Device designation for URO17(TM), Innovative urine test for Bladder Cancer
Dec 11, 2019
Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit
Dec 11, 2019
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
Nov 05, 2019
DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
Oct 29, 2019
Adolescent Suicide Up 87 Percent Over Last Decade; LGBT and American Indian/Alaskan Native Teens at Highest Risk
Sep 30, 2019
SkylineDx Confirms Positive Results First Independent Validation Skin Cancer Test